These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 8967706

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [Abstract] [Full Text] [Related]

  • 3. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
    Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM.
    J Rheumatol; 1997 Aug; 24(8):1489-94. PubMed ID: 9263140
    [Abstract] [Full Text] [Related]

  • 4. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
    van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW.
    Osteoporos Int; 2013 Apr; 24(4):1429-36. PubMed ID: 23011680
    [Abstract] [Full Text] [Related]

  • 7. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study.
    Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van't Hof MA, Lemmens JA.
    Ann Intern Med; 1993 Nov 15; 119(10):963-8. PubMed ID: 8105737
    [Abstract] [Full Text] [Related]

  • 8. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
    Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA.
    N Engl J Med; 1997 Aug 07; 337(6):382-7. PubMed ID: 9241127
    [Abstract] [Full Text] [Related]

  • 9. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
    Frediani B, Falsetti P, Baldi F, Acciai C, Filippou G, Marcolongo R.
    Bone; 2003 Oct 07; 33(4):575-81. PubMed ID: 14555261
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of calcium plus vitamin D supplementation during pregnancy in Brazilian adolescent mothers: a randomized, placebo-controlled trial.
    Diogenes ME, Bezerra FF, Rezende EP, Taveira MF, Pinhal I, Donangelo CM.
    Am J Clin Nutr; 2013 Jul 07; 98(1):82-91. PubMed ID: 23719547
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium.
    Hillman LS, Cassidy JT, Chanetsa F, Hewett JE, Higgins BJ, Robertson JD.
    Arthritis Rheum; 2008 Oct 07; 58(10):3255-63. PubMed ID: 18821668
    [Abstract] [Full Text] [Related]

  • 16. Effects of a multi-component exercise program and calcium-vitamin-D3-fortified milk on bone mineral density in older men: a randomised controlled trial.
    Kukuljan S, Nowson CA, Bass SL, Sanders K, Nicholson GC, Seibel MJ, Salmon J, Daly RM.
    Osteoporos Int; 2009 Jul 07; 20(7):1241-51. PubMed ID: 18958384
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.
    Hansen KE, Johnson RE, Chambers KR, Johnson MG, Lemon CC, Vo TN, Marvdashti S.
    JAMA Intern Med; 2015 Oct 07; 175(10):1612-21. PubMed ID: 26237520
    [Abstract] [Full Text] [Related]

  • 18. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
    Pitt P, Li F, Todd P, Webber D, Pack S, Moniz C.
    Thorax; 1998 May 07; 53(5):351-6. PubMed ID: 9708225
    [Abstract] [Full Text] [Related]

  • 19. Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients.
    Eastell R, Devogelaer JP, Peel NF, Chines AA, Bax DE, Sacco-Gibson N, Nagant de Deuxchaisnes C, Russell RG.
    Osteoporos Int; 2000 May 07; 11(4):331-7. PubMed ID: 10928223
    [Abstract] [Full Text] [Related]

  • 20. Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine.
    Yonemura K, Fukasawa H, Fujigaki Y, Hishida A.
    Am J Kidney Dis; 2004 Jan 07; 43(1):53-60. PubMed ID: 14712427
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.